BNGO - Bionano Genomics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
4.2400
+0.0900 (+2.17%)
At close: 3:39PM EST
Stock chart is not supported by your current browser
Previous Close4.1500
Open4.07
Bid2.25 x 1100
Ask4.50 x 900
Day's Range4.0700 - 4.3400
52 Week Range3.5000 - 10.0000
Volume3,031
Avg. Volume7,266
Market Cap42.539M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-6.74
Earnings DateFeb 25, 2019 - Mar 1, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est11.50
Trade prices are not sourced from all markets
  • ACCESSWIRE13 days ago

    These 4 Biotech Stocks Are Leading The Industry

    Premier Health Group (PHGRF) (PHGI), Neon Therapeutics Inc (NTGN), Bionano Genomics Inc (BNGO), and XBiotech Inc (XBIT) represent four biotech companies working to champion new treatments for consumers in the space. The Company has magnetized investors looking for opportunities in the biotech sector by strategically investing in products and services that demonstrate Premier's dedication to the industry, as well to patients simply looking for a means of feeling better. Premier Health Group (PHGRF) (PHGI) announced towards the end of last month that, further to itsnew release dated January 10, 2019, the Company has acquired all outstanding securities of Cloud Practice Inc. As a result of the acquisition, Cloud Practice's Founders, including CEO Jordan Visco, and entire support team, consisting of several software developers and sales staff, will join and work alongside the Premier Health team to offer tools and resources providing for better efficiency on a day-to-day basis for both physicians and customers.

  • GlobeNewswire13 days ago

    Bionano Genomics’ Saphyr® System Used for Highly Accurate Detection of the Genetic Disorder FSHD as an Alternative to Southern Blot

    SAN DIEGO, Feb. 06, 2019 -- Bionano Genomics, Inc.  (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr, a platform for ultra-sensitive and.

  • GlobeNewswirelast month

    Global Adoption of Bionano Genomics’ Saphyr® System Accelerating for Clinical Genomics Applications

    SAN DIEGO, Jan. 14, 2019 -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets the Saphyr system, which enables.

  • What does Bionano Genomics Inc’s (NASDAQ:BNGO) Balance Sheet Tell Us About Its Future?
    Simply Wall St.3 months ago

    What does Bionano Genomics Inc’s (NASDAQ:BNGO) Balance Sheet Tell Us About Its Future?

    Bionano Genomics Inc (NASDAQ:BNGO) is a small-cap stock with a market capitalization of US$68m. While investors primarily focus on the growth potential and competitive landscape of the small-cap companies, they Read More...

  • Benzinga7 months ago

    The IPO Outlook For The Week: A Light Slate Of Tech, Real Estate

    For a more comprehensive IPO calendar, check out the offering in Benzinga Cloud . Arlo Technologies, Inc. (ARLO) will issue more than 10.2 million shares between $18 and $20 Friday on the New York Stock ...